Paid Clinical Trials Lubbock

Discover 42 paid clinical trials in Lubbock, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 42

LumateperoneMulticenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

Recruiting

PHASE3

Sponsor:

Intra-Cellular Therapies, Inc.

Location:

Oklahoma City OK, Frisco TX, Austin TX, Colorado Springs COshow 38 more

Code:

NCT06372964

Conditions

Bipolar Depression

Eligibility Criteria

Sex: All

Age: 10 - 17

Healthy Volunteers: Not accepted

Interventions

Lumateperone

Placebo

Avmacol ESPrevention of Age-associated Cardiac and Vascular Dysfunction Using Avmacol ES

Recruiting

PHASE1

PHASE2

Sponsor:

Texas Tech University Health Sciences Center

Location:

Lubbock TX

Code:

NCT05408559

Conditions

Diastolic Dysfunction

Systolic Dysfunction

Diastolic Heart Failure

Eligibility Criteria

Sex: All

Age: 60 - 70+

Healthy Volunteers: Accepted

Interventions

Sulforaphane

Rilvegostomig & PembrolizumabA Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Lubbock TX, Fort Worth TX, Round Rock TX, Kingwood TXshow 53 more

Code:

NCT06692738

Conditions

Non-small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Rilvegostomig

Pembrolizumab

Carboplatin

Paclitaxel

Nab-paclitaxel

HAV vs. AVFTo Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis

Recruiting

PHASE3

Sponsor:

Humacyte, Inc.

Location:

Lubbock TX, Austin TX, San Antonio TX, Denver COshow 24 more

Code:

NCT05908084

Conditions

End Stage Renal Disease (ESRD)

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Acellular Tissue Engineered Vessel (ATEV)

AVF

Molecular Residual DiseaseEXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Recruiting

Sponsor:

Exact Sciences Corporation

Location:

Lubbock TX, Houston TX, Sioux Falls SD, Saint Louis Park MNshow 30 more

Code:

NCT06401421

Conditions

Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ctDNA MRD test

Nitrous OxideHand Held Nitrous Oxide Delivery Device

Recruiting

Sponsor:

Strata Medical Innovations

Location:

Lubbock TX

Code:

NCT02119403

Conditions

Anesthesia

Eligibility Criteria

Sex: All

Age: 3+

Healthy Volunteers: Not accepted

Interventions

There are no other inteventions.

Observational StudyInvestigating a Brief Virtual Seminar Series for Parents of Teens Ages 13-17

Recruiting

Sponsor:

Texas Tech University

Location:

Lubbock TX

Code:

NCT06865196

Conditions

Positive Parenting Skills

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Accepted

Interventions

Positive Parenting Seminar Series

GGAnnatto-derived GG for Statin-associated Myopathy

Recruiting

PHASE1

PHASE2

Sponsor:

Texas Tech University Health Sciences Center

Location:

Lubbock TX

Code:

NCT05312424

Conditions

Myopathy; Primary

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Accepted

Interventions

Placebo

Low GG

High GG

Heat Therapy & Omega 3Heat Therapy and Omega 3 on Cardio-Metabolic Health

Recruiting

Sponsor:

Texas Tech University

Location:

Lubbock TX

Code:

NCT04051034

Conditions

Hypertension

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Accepted

Interventions

Omega 3

Placebo

ALTB-268Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to Biologics

Recruiting

PHASE2

Sponsor:

AltruBio Inc.

Location:

Lubbock TX, Mansfield TX, Garland TX, San Antonio TXshow 19 more

Code:

NCT06109441

Conditions

Ulcerative Colitis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

ALTB-268